These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20888551)

  • 21. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P; Peterson ED
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Which, when, how?].
    Juárez Herrera U
    Arch Cardiol Mex; 2001; 71 Suppl 1():S85-90. PubMed ID: 11565353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
    Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Troponins and the indication for treatment with IIb/IIa inhibitors in acute coronary syndromes without ST-segment elevation. Is it time for an "INR" value of troponins?].
    Juárez Herrera U
    Arch Cardiol Mex; 2003; 73 Suppl 1():S79-83. PubMed ID: 12966651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.
    Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes.
    Ueland T; Aukrust P; Omdal TR; Damås JK; Endresen K; Ren F; Hysing J
    Int J Cardiol; 2011 Sep; 151(3):385-7. PubMed ID: 21782261
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycoprotein IIb/IIIa inhibitors in clinical practice.
    Maia F; Sá FC; Feres F
    Arq Bras Cardiol; 2009 Jan; 92(1):68-76. PubMed ID: 19219267
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracoronary glycoprotein IIb/IIIa inhibitors from questioning the logic to weighing the data.
    Berger PB; Best PJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):935-6. PubMed ID: 20850092
    [No Abstract]   [Full Text] [Related]  

  • 31. Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/Illa antagonists in non-ST elevation acute coronary syndrome.
    Philips Z; Claxton KP; Palmer S; Bojke L; Sculpher MJ
    Int J Technol Assess Health Care; 2006; 22(3):379-87. PubMed ID: 16984067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current therapy of non-ST-elevation acute coronary syndromes.
    Paxinos G; Katritsis DG
    Hellenic J Cardiol; 2012; 53(1):63-71. PubMed ID: 22275745
    [No Abstract]   [Full Text] [Related]  

  • 33. ST-segment elevation followed by progressive widening of the QRS complex.
    Czuriga D; Barta J; Rácz I; Edes I; Györy F; Czuriga I; Csanádi Z
    JAMA Intern Med; 2013 Apr; 173(7):490; discussion 491-2. PubMed ID: 23479024
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiology of non-ST elevation acute coronary syndrome].
    Iwai N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():275-80. PubMed ID: 22724215
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fondaparinux and invasive treatment of non-ST elevation acute coronary syndrome].
    Averkov OV
    Kardiologiia; 2008; 48(12):49-54. PubMed ID: 19076094
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is there a future for thrombolytic therapy in acute coronary syndrome-segment elevation ST].
    Guliarov MIu; Novikova NA; Sulimov VA
    Kardiologiia; 2011; 51(12):77-83. PubMed ID: 22304321
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of a selective strategy for glycoprotein IIb/IIIa inhibitors administration in non-ST segment elevation acute coronary syndromes].
    Georges JL; Charbonnel C; Convers-Domart R; Baron N; Leterme C; Galuscan G; Schwob J; Livarek B
    Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):271-7. PubMed ID: 20888551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.
    Dabbous OH; Anderson FA; Gore JM; Eagle KA; Fox KA; Mehta RH; Goldberg RJ; Agnelli G; Steg PG;
    Heart; 2008 Feb; 94(2):159-65. PubMed ID: 17575335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
    Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
    Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.